home / stock / crdl / crdl quote
Last: | $2.18 |
---|---|
Change Percent: | -0.93% |
Open: | $2.16 |
Close: | $2.18 |
High: | $2.21 |
Low: | $2.14 |
Volume: | 247,374 |
Last Trade Date Time: | 05/13/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$2.18 | $2.16 | $2.18 | $2.21 | $2.14 | 247,374 | 05-13-2024 |
$2.14 | $2.23 | $2.14 | $2.24 | $2.0528 | 320,409 | 05-10-2024 |
$2.21 | $2.05 | $2.21 | $2.22 | $1.98 | 889,099 | 05-09-2024 |
$2 | $2.01 | $2 | $2.01 | $1.95 | 242,651 | 05-08-2024 |
$1.98 | $2 | $1.98 | $2.04 | $1.95 | 172,389 | 05-07-2024 |
$2.02 | $2.03 | $2.02 | $2.08 | $1.96 | 211,110 | 05-06-2024 |
$1.99 | $1.94 | $1.99 | $2.05 | $1.9 | 284,004 | 05-03-2024 |
$1.98 | $2.06 | $1.98 | $2.07 | $1.94 | 283,562 | 05-02-2024 |
$2.06 | $2.02 | $2.06 | $2.0773 | $1.89 | 434,540 | 05-01-2024 |
$2.01 | $1.82 | $2.01 | $2.08 | $1.75 | 1,422,858 | 04-30-2024 |
$1.77 | $1.84 | $1.77 | $1.84 | $1.74 | 217,252 | 04-29-2024 |
$1.79 | $1.81 | $1.79 | $1.84 | $1.74 | 104,739 | 04-26-2024 |
$1.84 | $1.75 | $1.84 | $1.84 | $1.69 | 117,222 | 04-25-2024 |
$1.76 | $1.84 | $1.76 | $1.84 | $1.74 | 199,799 | 04-24-2024 |
$1.84 | $1.82 | $1.84 | $1.84 | $1.72 | 162,971 | 04-23-2024 |
$1.76 | $1.86 | $1.76 | $1.9 | $1.69 | 331,117 | 04-22-2024 |
$1.77 | $1.69 | $1.77 | $1.79 | $1.55 | 567,455 | 04-19-2024 |
$1.67 | $1.75 | $1.67 | $1.75 | $1.665 | 85,656 | 04-18-2024 |
$1.75 | $1.71 | $1.75 | $1.82 | $1.71 | 101,080 | 04-17-2024 |
$1.72 | $1.76 | $1.72 | $1.81 | $1.7 | 229,532 | 04-16-2024 |
News, Short Squeeze, Breakout and More Instantly...
Cardiol Therapeutics Inc. Company Name:
CRDL Stock Symbol:
NASDAQ Market:
Completed patient enrollment in the Phase II MAvERIC-Pilot study evaluating CardiolRx™ in patients with recurrent pericarditis, with topline results expected in Q2 2024 CardiolRx™ granted U.S. FDA Orphan Drug Designation for the treatment of pericarditis, which includes recurrent p...
Iochpe-Maxion S.A. ADR (IOCJY) is expected to report for quarter end 2023-12-31 The Alkaline Water Company Inc. (WTER) is expected to report for Q3 2024 Clover Leaf Capital Corp. (CLOE) is expected to report for Q4 2023 Silvergate Capital Corporation Class A (SICP) is expected to repo...